talazoparib
Talazoparib is a drug used to treat Breast Cancer, Advanced Solid Tumors, Breast Neoplasms, and other conditions. Talazoparib is being actively studied in 52 studies and prior, has been studied in 13.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Pfizer | The University of Texas MD Anderson Cancer Center | Aditya Bardia |
| National Cancer Institute (NCI) | M D Anderson Cancer Center | Atish Choudhury |
| Dana-Farber Cancer Institute | Washington University School of Medicine | Bryan Schneider, MD |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Recruiting
- Breast Cancer
- Talazoparib
- Avelumab
- Washington, District of Columbia
- +2 more
2022-03-14
Mar 14, 2022R
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Gemtuzumab Ozogamicin
- +4 more
- Buffalo, New YorkRoswell Park Cancer Institute
2022-02-25
Feb 25, 2022P
Completed
- Neoplasms
- talazoparib
- Changchun, Jilin, China
- +1 more
2022-01-12
Jan 12, 2022C
Recruiting
- Metastatic or Unresectable Melanoma
- Nivolumab
- Talazoparib
- Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2022-03-22
Mar 22, 2022S
Not yet recruiting
- Acute Myeloid Leukemia
- Talazoparib
- +2 more
- Stanford, CaliforniaStanford University
2021-10-28
Oct 28, 2021M
Active, not recruiting
- Breast Adenocarcinoma
- +4 more
- Laboratory Biomarker Analysis
- Talazoparib
- Houston, TexasM D Anderson Cancer Center
2022-02-09
Feb 9, 2022M
Recruiting
- Breast Cancer
- Talazoparib
- Sacituzumab Govitecan
- Boston, MassachusettsMassachusetts General Hospital Cancer Center
2021-10-25
Oct 25, 2021D
Recruiting
- Leukemia
- Talazoparib
- Boston, Massachusetts
- +1 more
2021-08-23
Aug 23, 2021U
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- Belinostat
- Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
2022-03-31
Mar 31, 2022T
Recruiting
- Recurrent Glioma
- +4 more
- Talazoparib
- Hong Kong, Hong KongDepartment of Clinical Oncology
2021-08-19
Aug 19, 2021D
Recruiting
- Metastatic Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- Talazoparib
- Tazemetostat
- Boston, Massachusetts
- +1 more
2021-07-12
Jul 12, 2021U
Recruiting
- HRD 100 Gene Expression High
- Triple Negative Breast Cancer
- Talazoparib
- Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
2022-03-15
Mar 15, 2022U
Active, not recruiting
- Acute Myeloid Leukemia
- Decitabine
- talazoparib
- Baltimore, MarylandUniversity of Maryland Greenebaum Comprehensive Cancer Center
2021-10-05
Oct 5, 2021N
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Talazoparib
- Temozolomide
- Bethesda, MarylandNational Cancer Institute LAO
2022-04-07
Apr 7, 2022M
Active, not recruiting
- Advanced Malignant Neoplasm
- +7 more
- Laboratory Biomarker Analysis
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-21
Feb 21, 2022M
Recruiting
- Metastatic Prostate Cancer
- Enzalutamide
- Talazoparib
- Badalona, Spain
- +8 more
2022-03-28
Mar 28, 2022H
Not yet recruiting
- Ovarian Cancer
- +2 more
- ZEN003694
- Talazoparib
- Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
2022-03-14
Mar 14, 2022K
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- ASTX727
- Indianapolis, Indiana
- +1 more
2021-09-28
Sep 28, 2021K
Recruiting
- TNBC - Triple-Negative Breast Cancer
- Gedatolisib
- Talazoparib
- Chicago, Illinois
- +4 more
2022-01-18
Jan 18, 2022N
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
- Talazoparib
- Selinexor
- Singapore, SingaporeNational University Hospital
2021-08-31
Aug 31, 2021N
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
- New Brunswick, New Jersey
- +2 more
2022-01-25
Jan 25, 2022M
Not yet recruiting
- Prostate Cancer Metastatic
- Telaglenastat
- Talazoparib
- Boston, MassachusettsMassachusetts General Hospital
2021-03-27
Mar 27, 2021Z
Active, not recruiting
- Triple Negative Breast Cancer
- ZEN003694
- Talazoparib
- Gilbert, Arizona
- +9 more
2022-02-07
Feb 7, 2022M
Recruiting
- Metastatic Renal Cell Carcinoma
- +2 more
- Talazoparib
- Avelumab
- Basking Ridge, New Jersey
- +6 more
2021-12-21
Dec 21, 2021S
Completed
- Childhood Solid Tumors
- Talazoparib
- +4 more
- Memphis, TennesseeSt. Jude Children's Research Hospital
2021-02-08
Feb 8, 2021